Skip to main content
main-content

01.12.2014 | Research | Ausgabe 1/2014 Open Access

Journal of Ovarian Research 1/2014

A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients

Zeitschrift:
Journal of Ovarian Research > Ausgabe 1/2014
Autoren:
Meiying Zhang, Yifeng He, Xiangjun Sun, Qing Li, Wenjing Wang, Aimin Zhao, Wen Di
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1757-2215-7-19) contains supplementary material, which is available to authorized users.
Meiying Zhang, Yifeng He contributed equally to this work.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

YFH, AMZ, and WD designed the study. MYZ performed the immunohistochemistry and immunofluorescence work. YFH and XJS independently reviewed the immunostained cancer tissue sections. WJW and QL performed the LCM and flow cytometry. YFH wrote the manuscript. All authors read and approved the final manuscript.

Abstract

Background

Tumor-associated macrophages (TAMs) are classified into two major phenotypes, M1 and M2. M1 TAMs suppress cancer progression, while M2 TAMs promote it. However, little is known regarding the role of TAMs in the development of ovarian cancer. Here, we investigated the relationship between TAM distribution patterns (density, microlocalization, and differentiation) and ovarian cancer histotypes, and we explored whether altered TAM distribution patterns influence long-term outcomes in ovarian cancer patients.

Methods

A total of 112 ovarian cancer patients were enrolled in this study, and the subjects were divided into two groups according to their survival (< 5 years vs. ≥ 5 years). Immunohistochemistry and immunofluorescence were used to determine the density, microlocalization, and differentiation status of TAMs in ovarian cancer tissues for each histotype. Kaplan-Meier survival and multivariate Cox regression analyses were used to evaluate the prognostic significance of TAM-related parameters in ovarian cancer.

Results

TAMs most frequently infiltrated into the cancer tissue of the serous histotype, followed by mucinous, undifferentiated, endometrioid, and clear cell histotypes (p = 0.049). The islet/stroma ratio of total TAMs varied among the cancer histotypes, with mucinous and undifferentiated cancers displaying the lowest and highest ratios, respectively (p = 0.005). The intratumoral TAM density significantly increased with increasing cancer stage and grade (p = 0.023 and 0.006, respectively). However, the overall M1/M2 TAM ratio decreased as the cancer stage increased (p = 0.012). In addition, the intra-islet M1/M2 ratio inversely correlated with the residual site size (p = 0.004). Among the TAM-related parameters, only the increased overall and intra-islet M1/M2 TAM ratios displayed prognostic significance in both the Kaplan-Meier survival and multivariate Cox regression analyses; however, the values of these two parameters did not differ significantly among the cancer histotypes.

Conclusions

The patients with increased overall or intra-islet M1/M2 TAM ratios presented with an improved 5-year prognosis. Nevertheless, the TAM distribution patterns did not influence the overall outcomes of different ovarian cancer histotypes.
Zusatzmaterial
Additional file 1: Tables S1-S14: Describe the multivariate Cox regression analytic results for the following TAM-related parameters (for the overall M1/M2 TAM ratio, see Table 4): total TAM density (Table S1); intra-islet TAM density (Table S2); intra-stromal TAM density (Table S3); overall M1 TAM density (Table S4); intra-islet M1 TAM density (Table S5); intra-stromal M1 TAM density (Table S6); overall M2 TAM density (Table S7); intra-islet M2 TAM density (Table S8); intra-stromal M2 TAM density (Table S9); islet/stroma ratio of total TAMs (Table S10); islet/stroma ratio of M1 TAMs (Table S11); islet/stroma ratio of M2 TAMs (Table S12); intra-islet M1/M2 TAM ratio (Table S13); and intra-stromal M1/M2 TAM ratio (Table S14). (PDF 805 KB)
Authors’ original file for figure 1
13048_2013_238_MOESM2_ESM.tiff
Authors’ original file for figure 2
13048_2013_238_MOESM3_ESM.tiff
Authors’ original file for figure 3
13048_2013_238_MOESM4_ESM.jpeg
Authors’ original file for figure 4
13048_2013_238_MOESM5_ESM.tiff
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2014

Journal of Ovarian Research 1/2014 Zur Ausgabe


 

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Meistgelesene Bücher aus dem Fachgebiet

2014 | Buch

Perikonzeptionelle Frauenheilkunde

Fertilitätserhalt, Prävention und Management von Schwangerschaftsrisiken

Ein Praxisbuch für alle, die in der Beratung und Betreuung von Schwangeren und Paaren mit Kinderwunsch tätig sind. Die Herausgeber und Autoren haben alle wichtigen Informationen zusammengetragen, um Frauen sicher zu beraten, zu betreuen und kompetent Verantwortung zu übernehmen.

Herausgeber:
Christian Gnoth, Peter Mallmann

2019 | Buch

Praxisbuch Gynäkologische Onkologie

Dieses kompakte und praxisrelevante Standardwerk richtet sich alle Ärzte in Klinik und Praxis, die Patientinnen mit bösartigen Tumoren des Genitales und der Mamma behandeln. Die 5. Auflage wurde komplett aktualisiert und auf der Basis …

Herausgeber:
Prof. Dr. Edgar Petru, Dr. Daniel Fink, Prof. Dr. Ossi R. Köchli, Prof. Dr. Sibylle Loibl

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Gynäkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise